 | • レポートコード：MRC2Q12-19195 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、注射用ロメフロキサシン塩酸塩のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 注射用ロメフロキサシン塩酸塩のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ロメフロキサシン塩酸塩の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ロメフロキサシン塩酸塩のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの注射用ロメフロキサシン塩酸塩の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の注射用ロメフロキサシン塩酸塩の売上および2028年までの予測に焦点を当てています。 注射用ロメフロキサシン塩酸塩のグローバル主要企業には、Shanxi PUDE Pharmaceutical、Shanghai Harvest Pharmaceutical、Jiangsu Lianshui Pharmaceutical、Fuan Pharmaceutical、Changzhou Lanling Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 注射用ロメフロキサシン塩酸塩市場は、タイプとアプリケーションによって区分されます。世界の注射用ロメフロキサシン塩酸塩市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.1g/ボトル、0.2g/ボトル 【アプリケーション別セグメント】 病院薬局、小売店薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 注射用ロメフロキサシン塩酸塩製品概要 - タイプ別市場（0.1g/ボトル、0.2g/ボトル） - アプリケーション別市場（病院薬局、小売店薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の注射用ロメフロキサシン塩酸塩販売量予測2017-2028 - 世界の注射用ロメフロキサシン塩酸塩売上予測2017-2028 - 注射用ロメフロキサシン塩酸塩の地域別販売量 - 注射用ロメフロキサシン塩酸塩の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別注射用ロメフロキサシン塩酸塩販売量 - 主要メーカー別注射用ロメフロキサシン塩酸塩売上 - 主要メーカー別注射用ロメフロキサシン塩酸塩価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.1g/ボトル、0.2g/ボトル） - 注射用ロメフロキサシン塩酸塩のタイプ別販売量 - 注射用ロメフロキサシン塩酸塩のタイプ別売上 - 注射用ロメフロキサシン塩酸塩のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、その他） - 注射用ロメフロキサシン塩酸塩のアプリケーション別販売量 - 注射用ロメフロキサシン塩酸塩のアプリケーション別売上 - 注射用ロメフロキサシン塩酸塩のアプリケーション別価格 ・北米市場 - 北米の注射用ロメフロキサシン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロメフロキサシン塩酸塩市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの注射用ロメフロキサシン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロメフロキサシン塩酸塩市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の注射用ロメフロキサシン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロメフロキサシン塩酸塩市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の注射用ロメフロキサシン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロメフロキサシン塩酸塩市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの注射用ロメフロキサシン塩酸塩市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ロメフロキサシン塩酸塩市場規模（トルコ、サウジアラビア） ・企業情報 Shanxi PUDE Pharmaceutical、Shanghai Harvest Pharmaceutical、Jiangsu Lianshui Pharmaceutical、Fuan Pharmaceutical、Changzhou Lanling Pharmaceutical ・産業チェーン及び販売チャネル分析 - 注射用ロメフロキサシン塩酸塩の産業チェーン分析 - 注射用ロメフロキサシン塩酸塩の原材料 - 注射用ロメフロキサシン塩酸塩の生産プロセス - 注射用ロメフロキサシン塩酸塩の販売及びマーケティング - 注射用ロメフロキサシン塩酸塩の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 注射用ロメフロキサシン塩酸塩の産業動向 - 注射用ロメフロキサシン塩酸塩のマーケットドライバー - 注射用ロメフロキサシン塩酸塩の課題 - 注射用ロメフロキサシン塩酸塩の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Lomefloxacin Hydrochloride for Injection Market
Due to the COVID-19 pandemic, the global Lomefloxacin Hydrochloride for Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 0.1g/Bottle accounting for % of the Lomefloxacin Hydrochloride for Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Lomefloxacin Hydrochloride for Injection market size is valued at US$ million in 2021, while the US and Europe Lomefloxacin Hydrochloride for Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lomefloxacin Hydrochloride for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Lomefloxacin Hydrochloride for Injection include Shanxi PUDE Pharmaceutical, Shanghai Harvest Pharmaceutical, Jiangsu Lianshui Pharmaceutical, Fuan Pharmaceutical and Changzhou Lanling Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Lomefloxacin Hydrochloride for Injection Scope and Segment
Lomefloxacin Hydrochloride for Injection market is segmented by Specification and by Application. Players, stakeholders, and other participants in the global Lomefloxacin Hydrochloride for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Specification and by Application for the period 2017-2028.
Segment by Specification
0.1g/Bottle
0.2g/Bottle
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
Shanxi PUDE Pharmaceutical
Shanghai Harvest Pharmaceutical
Jiangsu Lianshui Pharmaceutical
Fuan Pharmaceutical
Changzhou Lanling Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Lomefloxacin Hydrochloride for Injection Product Introduction
1.2 Market by Specification
1.2.1 Global Lomefloxacin Hydrochloride for Injection Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 0.1g/Bottle
1.2.3 0.2g/Bottle
1.3 Market by Application
1.3.1 Global Lomefloxacin Hydrochloride for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lomefloxacin Hydrochloride for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Lomefloxacin Hydrochloride for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Lomefloxacin Hydrochloride for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lomefloxacin Hydrochloride for Injection Sales by Region
2.4.1 Global Lomefloxacin Hydrochloride for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Lomefloxacin Hydrochloride for Injection by Region (2023-2028)
2.5 Global Lomefloxacin Hydrochloride for Injection Revenue by Region
2.5.1 Global Lomefloxacin Hydrochloride for Injection Revenue by Region (2017-2022)
2.5.2 Global Lomefloxacin Hydrochloride for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lomefloxacin Hydrochloride for Injection Sales by Manufacturers
3.1.1 Global Top Lomefloxacin Hydrochloride for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Lomefloxacin Hydrochloride for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lomefloxacin Hydrochloride for Injection in 2021
3.2 Global Lomefloxacin Hydrochloride for Injection Revenue by Manufacturers
3.2.1 Global Lomefloxacin Hydrochloride for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Lomefloxacin Hydrochloride for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lomefloxacin Hydrochloride for Injection Revenue in 2021
3.3 Global Lomefloxacin Hydrochloride for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lomefloxacin Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lomefloxacin Hydrochloride for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Lomefloxacin Hydrochloride for Injection Sales by Specification
4.1.1 Global Lomefloxacin Hydrochloride for Injection Historical Sales by Specification (2017-2022)
4.1.2 Global Lomefloxacin Hydrochloride for Injection Forecasted Sales by Specification (2023-2028)
4.1.3 Global Lomefloxacin Hydrochloride for Injection Sales Market Share by Specification (2017-2028)
4.2 Global Lomefloxacin Hydrochloride for Injection Revenue by Specification
4.2.1 Global Lomefloxacin Hydrochloride for Injection Historical Revenue by Specification (2017-2022)
4.2.2 Global Lomefloxacin Hydrochloride for Injection Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Lomefloxacin Hydrochloride for Injection Revenue Market Share by Specification (2017-2028)
4.3 Global Lomefloxacin Hydrochloride for Injection Price by Specification
4.3.1 Global Lomefloxacin Hydrochloride for Injection Price by Specification (2017-2022)
4.3.2 Global Lomefloxacin Hydrochloride for Injection Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Lomefloxacin Hydrochloride for Injection Sales by Application
5.1.1 Global Lomefloxacin Hydrochloride for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Lomefloxacin Hydrochloride for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Lomefloxacin Hydrochloride for Injection Sales Market Share by Application (2017-2028)
5.2 Global Lomefloxacin Hydrochloride for Injection Revenue by Application
5.2.1 Global Lomefloxacin Hydrochloride for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Lomefloxacin Hydrochloride for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lomefloxacin Hydrochloride for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Lomefloxacin Hydrochloride for Injection Price by Application
5.3.1 Global Lomefloxacin Hydrochloride for Injection Price by Application (2017-2022)
5.3.2 Global Lomefloxacin Hydrochloride for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lomefloxacin Hydrochloride for Injection Market Size by Specification
6.1.1 North America Lomefloxacin Hydrochloride for Injection Sales by Specification (2017-2028)
6.1.2 North America Lomefloxacin Hydrochloride for Injection Revenue by Specification (2017-2028)
6.2 North America Lomefloxacin Hydrochloride for Injection Market Size by Application
6.2.1 North America Lomefloxacin Hydrochloride for Injection Sales by Application (2017-2028)
6.2.2 North America Lomefloxacin Hydrochloride for Injection Revenue by Application (2017-2028)
6.3 North America Lomefloxacin Hydrochloride for Injection Market Size by Country
6.3.1 North America Lomefloxacin Hydrochloride for Injection Sales by Country (2017-2028)
6.3.2 North America Lomefloxacin Hydrochloride for Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Lomefloxacin Hydrochloride for Injection Market Size by Specification
7.1.1 Europe Lomefloxacin Hydrochloride for Injection Sales by Specification (2017-2028)
7.1.2 Europe Lomefloxacin Hydrochloride for Injection Revenue by Specification (2017-2028)
7.2 Europe Lomefloxacin Hydrochloride for Injection Market Size by Application
7.2.1 Europe Lomefloxacin Hydrochloride for Injection Sales by Application (2017-2028)
7.2.2 Europe Lomefloxacin Hydrochloride for Injection Revenue by Application (2017-2028)
7.3 Europe Lomefloxacin Hydrochloride for Injection Market Size by Country
7.3.1 Europe Lomefloxacin Hydrochloride for Injection Sales by Country (2017-2028)
7.3.2 Europe Lomefloxacin Hydrochloride for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lomefloxacin Hydrochloride for Injection Market Size by Specification
8.1.1 Asia Pacific Lomefloxacin Hydrochloride for Injection Sales by Specification (2017-2028)
8.1.2 Asia Pacific Lomefloxacin Hydrochloride for Injection Revenue by Specification (2017-2028)
8.2 Asia Pacific Lomefloxacin Hydrochloride for Injection Market Size by Application
8.2.1 Asia Pacific Lomefloxacin Hydrochloride for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Lomefloxacin Hydrochloride for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Lomefloxacin Hydrochloride for Injection Market Size by Region
8.3.1 Asia Pacific Lomefloxacin Hydrochloride for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Lomefloxacin Hydrochloride for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Lomefloxacin Hydrochloride for Injection Market Size by Specification
9.1.1 Latin America Lomefloxacin Hydrochloride for Injection Sales by Specification (2017-2028)
9.1.2 Latin America Lomefloxacin Hydrochloride for Injection Revenue by Specification (2017-2028)
9.2 Latin America Lomefloxacin Hydrochloride for Injection Market Size by Application
9.2.1 Latin America Lomefloxacin Hydrochloride for Injection Sales by Application (2017-2028)
9.2.2 Latin America Lomefloxacin Hydrochloride for Injection Revenue by Application (2017-2028)
9.3 Latin America Lomefloxacin Hydrochloride for Injection Market Size by Country
9.3.1 Latin America Lomefloxacin Hydrochloride for Injection Sales by Country (2017-2028)
9.3.2 Latin America Lomefloxacin Hydrochloride for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Lomefloxacin Hydrochloride for Injection Market Size by Specification
10.1.1 Middle East and Africa Lomefloxacin Hydrochloride for Injection Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Lomefloxacin Hydrochloride for Injection Revenue by Specification (2017-2028)
10.2 Middle East and Africa Lomefloxacin Hydrochloride for Injection Market Size by Application
10.2.1 Middle East and Africa Lomefloxacin Hydrochloride for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lomefloxacin Hydrochloride for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Lomefloxacin Hydrochloride for Injection Market Size by Country
10.3.1 Middle East and Africa Lomefloxacin Hydrochloride for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lomefloxacin Hydrochloride for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shanxi PUDE Pharmaceutical
11.1.1 Shanxi PUDE Pharmaceutical Corporation Information
11.1.2 Shanxi PUDE Pharmaceutical Overview
11.1.3 Shanxi PUDE Pharmaceutical Lomefloxacin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shanxi PUDE Pharmaceutical Lomefloxacin Hydrochloride for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanxi PUDE Pharmaceutical Recent Developments
11.2 Shanghai Harvest Pharmaceutical
11.2.1 Shanghai Harvest Pharmaceutical Corporation Information
11.2.2 Shanghai Harvest Pharmaceutical Overview
11.2.3 Shanghai Harvest Pharmaceutical Lomefloxacin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Shanghai Harvest Pharmaceutical Lomefloxacin Hydrochloride for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Shanghai Harvest Pharmaceutical Recent Developments
11.3 Jiangsu Lianshui Pharmaceutical
11.3.1 Jiangsu Lianshui Pharmaceutical Corporation Information
11.3.2 Jiangsu Lianshui Pharmaceutical Overview
11.3.3 Jiangsu Lianshui Pharmaceutical Lomefloxacin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Jiangsu Lianshui Pharmaceutical Lomefloxacin Hydrochloride for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangsu Lianshui Pharmaceutical Recent Developments
11.4 Fuan Pharmaceutical
11.4.1 Fuan Pharmaceutical Corporation Information
11.4.2 Fuan Pharmaceutical Overview
11.4.3 Fuan Pharmaceutical Lomefloxacin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Fuan Pharmaceutical Lomefloxacin Hydrochloride for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fuan Pharmaceutical Recent Developments
11.5 Changzhou Lanling Pharmaceutical
11.5.1 Changzhou Lanling Pharmaceutical Corporation Information
11.5.2 Changzhou Lanling Pharmaceutical Overview
11.5.3 Changzhou Lanling Pharmaceutical Lomefloxacin Hydrochloride for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Changzhou Lanling Pharmaceutical Lomefloxacin Hydrochloride for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Changzhou Lanling Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lomefloxacin Hydrochloride for Injection Industry Chain Analysis
12.2 Lomefloxacin Hydrochloride for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lomefloxacin Hydrochloride for Injection Production Mode & Process
12.4 Lomefloxacin Hydrochloride for Injection Sales and Marketing
12.4.1 Lomefloxacin Hydrochloride for Injection Sales Channels
12.4.2 Lomefloxacin Hydrochloride for Injection Distributors
12.5 Lomefloxacin Hydrochloride for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lomefloxacin Hydrochloride for Injection Industry Trends
13.2 Lomefloxacin Hydrochloride for Injection Market Drivers
13.3 Lomefloxacin Hydrochloride for Injection Market Challenges
13.4 Lomefloxacin Hydrochloride for Injection Market Restraints
14 Key Findings in The Global Lomefloxacin Hydrochloride for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer